Senseonics Holdings (SENS) Net Equity Issued and Repurchased (2014 - 2026)
Senseonics Holdings (SENS) posted quarterly Net Equity Issued and Repurchased of $3.5 million for Q1 2026, down 86.8% year-over-year from $26.5 million in Q1 2025, and up 114.68% quarter-over-quarter from -$23.8 million in Q4 2025.
Senseonics Holdings (SENS) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Net Equity Issued and Repurchased for 11 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased fell 86.8% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $5.4 million (down 79.94% YoY), while the FY2025 annual figure was $28.3 million, up 642.36% from the prior year.
- Net Equity Issued and Repurchased climbed to $3.5 million in Q1 2026 per SENS's latest filing, from -$23.8 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $34.4 million in Q1 2023 and bottomed at -$27.0 million in Q2 2023.
- Historically, Net Equity Issued and Repurchased has averaged $4.7 million across 5 years, with a median of $3.5 million in 2026.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 26356.0% in 2025 and fell as far as 16181.76% in 2025.
- Senseonics Holdings' Net Equity Issued and Repurchased stood at -$22.4 million in 2022, then retreated by 20.54% to -$27.0 million in 2023, then surged by 100.55% to $148000.0 in 2024, then slumped by 16181.76% to -$23.8 million in 2025, then jumped by 114.68% to $3.5 million in 2026.
- Business Quant data shows SENS's Net Equity Issued and Repurchased at $3.5 million in Q1 2026, -$23.8 million in Q4 2025, and $25.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Senseonics Holdings | 560.79 Mn | 320.18 Mn | 8.56 Mn | 50.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.00 Mn |
| Jun 30, 2026 | 50.00 Mn |
| Mar 31, 2026 | 3.49 Mn |
| Mar 31, 2026 | 3.49 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Jun 30, 2025 | 25.67 Mn |
| Jun 30, 2025 | 25.67 Mn |
| Mar 31, 2025 | 26.46 Mn |
| Mar 31, 2025 | 26.46 Mn |
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Jun 30, 2023 | -27.00 Mn |
| Jun 30, 2023 | -27.00 Mn |
| Mar 31, 2023 | 34.40 Mn |
| Mar 31, 2023 | 34.40 Mn |
| Dec 31, 2022 | -22.40 Mn |
| Dec 31, 2022 | -22.40 Mn |